Michael Gnant
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies 189
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 91
- HER2/EGFR in Cancer Research 87
- Bone health and treatments 59
- Endocrinology, Diabetes and Metabolism top 0.05%
- Surgery top 0.1%
- Genetics top 0.1%
- Estrogen and related hormone effects 93
-
- Advanced Breast Cancer Therapies 135
-
- Breast Lesions and Carcinomas 48
-
- Radiopharmaceutical Chemistry and Applications 38
- Co-authors
- Nadia HarbeckR. JakeszE M KohnerDavid R. HaddenDonna WrightMatthewsR R HolmanR. C. Turner
- Journals
- Journal of Clinical Oncology (88 papers)Cancer Research (36 papers)Annals of Oncology (28 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Michael Gnant
531 papers receiving 36.7k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 10.0k
- Oncology 13.1k
- Endocrinology, Diabetes and Metabolism 7.6k
- Surgery 8.8k
- Genetics 5.0k
Countries citing papers authored by Michael Gnant
This map shows the geographic impact of Michael Gnant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gnant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gnant more than expected).
Fields of papers citing papers by Michael Gnant
This network shows the impact of papers produced by Michael Gnant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gnant. The network helps show where Michael Gnant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Gnant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 1 | |
| 11 | 2019 | 33 | |
| 12 | 2017 | 32 | |
| 13 | A Phase II study of the safety and efficacy of alpelisib or buparlisib plus letrozole in neoadjuvant treatment of postmenopausal women with HR+/HER2–, PIK3CA mutant or wild-type breast cancer. | 2015 | 1 |
| 14 | 2014 | 55 | |
| 15 | 2013 | 77 | |
| 16 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifenbreakdown → | 2009 | 581 |
| 17 | アジュバント内分泌療法へのゾレドロン酸(ZOL)追加はホルモン応答性早期乳房腫瘍(HREBC)の閉経前女性の無病生存(DF)及び非再発生存(RFS)を改善する:オーストリア乳房腫瘍及び結腸直腸腫瘍研究グループ12(ABCSG-12)試験の多変量解析 | 2009 | 1 |
| 18 | 2005 | 0 | |
| 19 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 2001 | 159 |
| 20 | Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.breakdown → | 1991 | 1528 |
About Michael Gnant
Michael Gnant is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 555 papers that have together received 37.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (189 papers), Advanced Breast Cancer Therapies (135 papers), Estrogen and related hormone effects (93 papers), Cancer Treatment and Pharmacology (91 papers), HER2/EGFR in Cancer Research (87 papers), Bone health and treatments (59 papers), Breast Lesions and Carcinomas (48 papers) and Radiopharmaceutical Chemistry and Applications (38 papers). The work is most often cited by research in Cancer Research (10.0k citations), Oncology (13.1k citations) and Endocrinology, Diabetes and Metabolism (7.6k citations). Michael Gnant has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Nadia Harbeck, R. Jakesz, E M Kohner, David R. Hadden, Donna Wright, Matthews, R R Holman, R. C. Turner, Honora H. McElroy and C A Cull. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Care and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.